Bioceres (BIOX) 6-K: Noteholders accelerate; suit on Nov 11, 2025

Bioceres Crop Solutions (BIOX) reported that noteholders delivered a Declaration of Acceleration on its convertible and non-convertible notes on November 10, 2025, alleging uncured defaults.

Rhea-AI Filing Summary

Bioceres Crop Solutions (BIOX) reported that noteholders delivered a Declaration of Acceleration on its convertible and non-convertible notes on November 10, 2025, alleging uncured defaults. On November 11, 2025, these holders filed a lawsuit in New York Supreme Court seeking payment in full under the note agreements.

The company disputes the allegations and the purported effect of the acceleration and says it will vigorously defend its position. The filing also notes that this 6-K is incorporated by reference into existing Form F-3 and S-8 registration statements.

Insights

Credit & Legal Risk Analyst

Acceleration notice and lawsuit raise credit and legal risk.

Bioceres received an acceleration notice on its convertible and non-convertible notes on November 10, 2025, followed by a lawsuit on November 11, 2025 seeking payment in full under the agreements. Acceleration generally demands immediate repayment, which can pressure liquidity if enforced.

The company disputes the alleged defaults and the acceleration’s effect, indicating it will defend the case. Outcomes hinge on contract terms and court determinations; holder decisions and legal timelines will influence near-term developments.

The proceeding is filed in the New York Supreme Court. Subsequent filings may provide details on any interim orders or negotiated resolutions that could affect timing and cash needs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bioceres Crop Solutions (BIOX) disclose in its Form 6-K?

The company received an acceleration notice on its convertible and non-convertible notes on November 10, 2025, and noteholders filed a lawsuit on November 11, 2025.

Who are the noteholders involved in the BIOX acceleration and lawsuit?

Convertible noteholders include Jasper Lake Ventures One LLC, Liminality Partners, LP, and Redwood Enhanced Income Corp.; Solel-Bioceres SPV, L.P. holds the non-convertible notes.

What court is hearing the BIOX noteholder lawsuit?

The case is in the Supreme Court of the State of New York, County of New York.

How is Bioceres (BIOX) responding to the acceleration and lawsuit?

The company disputes the allegations and the acceleration’s purported effect and intends to vigorously defend its position.

Are there any amounts or payment figures disclosed for the BIOX notes?

The disclosure states noteholders seek payment in full under the agreements; specific amounts are not provided in the excerpt.

Does this 6-K relate to other Bioceres registration statements?

Yes. It is incorporated by reference into Bioceres’ Form F-3 (No. 333-284195) and Form S-8 (Nos. 333-271941 and 333-266333).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 01:01 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of November 2025

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x                               Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXPLANATORY NOTE

This Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (Registration No. 333-284195) and Form S-8 (Registration Nos. 333-271941 and 333-266333).

Acceleration Notice under Convertible and Non-Convertible Note Purchase Agreements

On November 10, 2025, Bioceres Crop Solutions Corp. (the “Company”) received a Declaration of Acceleration of Notes (“Acceleration Notice”) from (i) Jasper Lake Ventures One LLC (“Jasper Lake”), Liminality Partners, LP and Redwood Enhanced Income Corp, in their respective capacities as holders (collectively, the “Convertible Noteholders”) of notes issued and outstanding under that certain Note Purchase Agreement dated August 5, 2022 (as amended by the First Amendment to Note Purchase Agreement dated June 18, 2025) (the “Convertible Note Purchase Agreement”) by and among the Company, as issuer, the Convertible Noteholders, as purchasers, and Wilmington Savings Fund, FSB, as collateral agent and (ii) Solel-Bioceres SPV, L.P., in its capacity as holder (the “Non-Convertible Noteholder”) of notes issued under that certain Note Purchase Agreement dated August 5, 2022 (as amended by the First Amendment to Note Purchase Agreement dated June 18, 2025) (the “Non-Convertible Note Purchase Agreement”) by and among the Company, as issuer, the Non-Convertible Noteholder, as purchaser, and Agent, as collateral agent. The Acceleration Notice alleges that defaults occurred under the Convertible Note Purchase Agreement and Non-Convertible Note Purchase Agreement, and such defaults remain uncured and were continuing as of the date of the Acceleration Notice.

On November 11, 2025, the Convertible Noteholders and the Non-Convertible Noteholder commenced a lawsuit against the Company and certain of its subsidiaries and affiliates for the payment in full of the amounts due under the Convertible Note Purchase Agreement and Non-Convertible Note Purchase Agreement, captioned Jasper Lake Ventures One LLC, Redwood Enhanced Income Corp., Liminality Partners LP and Solel-Bioceres SPV, LP vs. Bioceres Crop Solutions Corp., et al in the Supreme Court of the State of New York, County of New York (the “Proceeding”).

The Company disputes the allegations and the purported effect of the Acceleration Notice (as well as any prior notices from the Convertible Noteholders and Non-Convertible Noteholder). The Company also disputes the alleged facts asserted by the Convertible Noteholders and the Non-Convertible Noteholder in the Proceeding, and intends to vigorously defend its position in the Proceeding. Moreover, the Company expressly reserves all rights against the Convertible Noteholders and Non-Convertible Noteholder, including Jasper Lake.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIOCERES CROP SOLUTIONS CORP.
	(Registrant)
Dated: November 12, 2025	By:	/s/  Federico Trucco
	Name:	Federico Trucco
	Title:	Chief Executive Officer